Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
517.40
Change Change %
2.30 0.45%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
516.90
Change Change %
1.95 0.38%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Religare
N/A
11-11-2016 Buy 699.05 875.00
N/A
Closed Long (1Y)
11-11-2017

Religare upgrades Sun Pharma to buy from hold

Religare in a note said that Sun Pharma reported a stellar Q2 with strong EBITDA margins and profit after tax. It sees multiple near-term triggers for the stock such as resolution of issues at Mohali and Halol plants, upside from gBenicar's authorised launch and above-expected Ranbaxy's synergies. It adds that post the recent correction, the stock appears to be favourably valued at the lower end of its historical band and Religare has upgraded Sun Pharma to buy from hold for target price of Rs 875.

Top